Company Search:
Advanced Search
Sponsored Links
ALK-Abello A/S Company Snapshot
ALK-Abello A/S operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Christian Hansen Holding with three other pharmaceutical manufacturers in Europe: Transgene of France (2016 sales of 8.73 million Euro [US$10.29 million] of which 72% was Research & Development Tax Credit), Biosearch SA of Spain (22.85 million Euro [US$26.94 million] of which 96% was Product Sales), and Bonesupport Holding AB which is based in Sweden (104.60 million Swedish Kronor [US$12.41 million] of which 76% was CERAMENT BVF).

Sales Analysis. Christian Hansen Holding reported sales of 3.01 billion Danish Kroner (US$475.99 million) for the year ending December of 2016. This represents an increase of 17.0% versus 2015, when the company's sales were 2.57 billion Danish Kroner. This was the third consecutive year of growth at Christian Hansen Holding. Sales of Scit/slit Drops saw an increase of 18.7% in 2016, from 1.85 billion Danish Kroner to 2.19 billion Danish Kroner.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
ALK-Abello A/S
  Stock Performance Chart for ALK-Abello A/S
  Stock Data: Recent Stock Performance:
  Current Price (11/17/2017): 901.00
(Figures in Danish Kroner)
1 Week -3.2%   13 Weeks -10.6%  
4 Weeks -5.2%   52 Weeks -0.9%  
ALK-Abello A/S Key Data:
  Ticker: ALK B Country: Denmark
  Exchanges: CPH Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2016 Sales 3,005,000,000
(Year Ending Jan 2017).
Employees: 2,123
  Currency: Danish Kroner Market Cap: 8,862,881,116
  Fiscal Yr Ends: December Shares Outstanding: 9,836,716
  Share Type: B Stamaktie Closely Held Shares: 4,079,695
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.